Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 29,700 shares at $135.29 ($4.1M) on 2020-11-02, disclosed to the SEC on 2020-11-04.
Open-market sale of $4.1M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.29 | 1,500 | $203K | 5.0% |
| 2 | $136.06 | 6,604 | $899K | 22.1% |
| 3 | $136.06 | 6,604 | $899K | 22.1% |
| 4 | $136.97 | 1,200 | $164K | 4.0% |
| 5 | $138.40 | 800 | $111K | 2.7% |
| 6 | $139.25 | 400 |
| $56K |
| 1.4% |
| 7 | $135.42 | 200 | $27K | 0.7% |
| 8 | $136.60 | 2,198 | $300K | 7.4% |
| 9 | $136.60 | 2,198 | $300K | 7.4% |
| 10 | $137.56 | 3,898 | $536K | 13.2% |
| 11 | $137.56 | 3,898 | $536K | 13.2% |
| 12 | $138.43 | 200 | $28K | 0.7% |
| Total | $136.65 avg | 29,700 | $4.1M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |